Table 1:
Participants | N=11 |
---|---|
Age (median; range) | 49 (27-60) |
Gender: | |
Male (n; %) | 8 (72%) |
Female (n; %) | 3 (23%) |
Race: | |
Black (n; %) | 10 (91%) |
White (n; %) | 1 (9%) |
Smoker (n; %) | 2 (18%) |
CD4 count at entry (median; range) (cells/uL) | 529 (172-1062) |
CD4 count nadir (median; range) (cells/uL) | 129 (24-233) |
Duration of ART (median; range) (years) | 7(3-13) |
Viral load at entry (median; range) (copies/mL) | <20 (<20-137) |
hsCRP (median; range) (mg/L) | 4 (1.6*-9.7) |
Total Cholesterol (median; range) (mg/dL) | 170 (106-239) |
LDL Cholesterol (median; range) (mg/dL) | 103 (45-152) |
One participant fulfilled enrollment criteria of hsCRP ≥ 2mg/dL at screening visit but was below that level at entry